“Microbiome Skin Formulation Development – A CRO’s Perspective”

Session Description: 

This session discusses the development of skin formulations containing the microbiome. The conundrum of preserving the product when the active moiety itself is causing the microbial bioburden will be discussed. The sensitive nature of the microbiome, the handling of it during the manufacturing process and its compatibility with harsh chemicals will be presented. Supply-Chain, manufacturing and quality control aspects are worth evaluating when developing the formulations for the regulated drug product world. 

Session Date & Time: 
Tuesday, October 3, 2017 - 10:00am to 10:35am